1.
Rev. Col. Bras. Cir
;
34(4): 277-278, jul.-ago. 2007. ilus
Article
in Portuguese
| LILACS
| ID: lil-463782
ABSTRACT
We present a case of non-resectable head pancreatic cancer by mesenteric venous invasion in which treatment with Gemcitabine (Gemzar) 1.000 mg/m 2 weekly for 3 weeks, followed by a 1-week rest, normalized CA 19.9 and promoted tumor resecability in a second operation (ultrasound, helicoidal tomography and magnetic ressonance exams). The value of the adjuvant treatment (radiochemotherapy) and the association with immunotherapy (Interferon) is discussed.